What Are the Side Effects of Resveratrol? GI, Bleeding, Estrogen and Drug Interactions
Resveratrol causes dose-dependent nausea and diarrhea above about 1 g a day, inhibits platelets and the liver enzymes CYP3A4, CYP2D6 and CYP2C9 at 1 g a day, and acts on estrogen receptors; typical 150–500 mg doses are usually tolerated but drug interactions deserve a check.
Key takeaways
- In a 29-day study of 40 volunteers, resveratrol was safe but 2.5 g and 5 g daily caused mild to moderate gastrointestinal symptoms.[2]
- At 1 g a day for four weeks, resveratrol inhibited CYP3A4, CYP2D6 and CYP2C9, enzymes that metabolize statins, antidepressants and PDE5 inhibitors.[7]
- Resveratrol inhibits platelet aggregation in laboratory studies, so men on anticoagulants or antiplatelet drugs and anyone facing surgery should be cautious.[3][4]
- It binds estrogen receptors alpha and beta as a mixed agonist/antagonist, a consideration for men on testosterone therapy.[5][6]
- Typical supplemental doses of 150–500 mg are usually well tolerated; the real risk is drug interactions, so check with a pharmacist.
What is resveratrol, and why do men take it?
Resveratrol is a polyphenolic compound found in red grapes, berries, peanuts, and Japanese knotweed. You’ve probably heard of it through the “French Paradox”, the observation that French populations had lower rates of heart disease despite high dietary fat intake, with red wine as the proposed explanation.
That story launched a supplement industry around resveratrol, with marketing claims spanning anti-aging, cardiovascular protection, sirtuin activation, and cancer prevention. For how these compounds fit alongside physician-supervised protocols, see our overview of peptides for anti-aging. The preclinical research has been genuinely interesting, but the side effect profile deserves equal airtime, especially for men taking medications or managing hormone-related health concerns. Our guide to NADH and cellular energy covers a separate part of the discussion around cellular energy and sirtuins.
What are the gastrointestinal side effects of resveratrol?
Gastrointestinal complaints are the most common side effects of resveratrol. In 40 healthy volunteers taking 0.5–5 g daily for 29 days, the 2.5 g and 5 g doses caused mild to moderate GI symptoms, while single doses up to 5 g produced no serious adverse events.[1][2] Phase I trials documented dose-dependent symptoms:
“Resveratrol was safe, but the 2.5 and 5 g doses caused mild to moderate gastrointestinal symptoms.”
| Side effect | Evidence | Dose where seen | Who should be careful |
|---|---|---|---|
| Gastrointestinal symptoms | Phase I single- and repeat-dose trials[1][2] | 2.5 g a day and above | Anyone at high doses |
| Antiplatelet effect | Laboratory and animal studies[3][4] | Not established in humans | Men on anticoagulants or antiplatelet drugs; before surgery |
| Inhibition of CYP3A4, CYP2D6, CYP2C9 | 42-volunteer study, 4 weeks[7] | 1 g a day | Men on statins, calcium-channel blockers, SSRIs, PDE5 inhibitors |
| Estrogen-receptor binding | Cell studies[5][6] | Not established in humans | Men on testosterone therapy; estrogen-sensitive conditions |
| Lower IGF-1 and IGFBP-3 | 40 volunteers, 29 days[2] | All doses; most at 2.5 g | Unknown clinical significance |
- Nausea: reported at doses above 1,000 mg/day in multiple studies
- Diarrhea: the most common dose-limiting side effect, particularly at 2,500 mg/day
- Abdominal pain and cramping: more common with higher doses on an empty stomach
- Flatulence and bloating: likely related to resveratrol's effects on gut microbiome composition
In a phase I pharmacokinetic study, Boocock et al. found that single doses up to 5,000 mg were tolerated, but GI side effects were common above 1,000 mg. In the 29-day repeat-dose study, the 2.5 g and 5 g daily doses caused mild to moderate gastrointestinal symptoms.[2]
Practical Mitigation
Most men taking resveratrol at standard supplemental doses (150–500 mg/day) do not experience significant GI issues. For those who do:
- Take with food to reduce gastric irritation
- Start with a lower dose and increase gradually
- Use trans-resveratrol formulations, which tend to be better tolerated than cis-resveratrol
- Consider micronized or liposomal forms that may improve absorption and reduce GI exposure
Does resveratrol thin the blood?
Resveratrol has demonstrated significant antiplatelet activity in both in vitro and in vivo studies. It inhibits platelet aggregation through multiple mechanisms, including suppression of cyclooxygenase-1 (COX-1), thromboxane A2 synthesis, and ADP-induced platelet activation.[3][4]
This antiplatelet activity is part of resveratrol's proposed cardiovascular benefit. Reduced platelet aggregation is associated with lower risk of blood clots, stroke, and myocardial infarction. However, this same property becomes a safety concern in specific situations:
When Blood Thinning Becomes a Risk
- Men taking anticoagulants: warfarin, apixaban (Eliquis), rivaroxaban (Xarelto), dabigatran (Pradaxa). Adding resveratrol may increase bleeding risk beyond the therapeutic range
- Men taking antiplatelet drugs: aspirin, clopidogrel (Plavix). Additive antiplatelet effects increase bruising and bleeding risk
- Pre-surgical patients: resveratrol should be discontinued at least 2 weeks before elective surgery due to increased intraoperative bleeding risk
- Men taking daily NSAIDs: ibuprofen, naproxen, and other NSAIDs also affect platelet function, creating a compounding effect
Men who notice increased bruising, prolonged bleeding from minor cuts, or nosebleeds after starting resveratrol should discontinue use and consult their physician.
Is resveratrol estrogenic?
One of the lesser-discussed aspects of resveratrol is its structural similarity to diethylstilbestrol (DES), a synthetic estrogen. Research has confirmed that resveratrol can bind to both estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ).[5]
But the estrogenic picture is more complex than simple agonism. Bowers et al. demonstrated that resveratrol acts as a mixed agonist/antagonist at estrogen receptors, meaning it can activate estrogen signaling in some tissue contexts while blocking it in others.[6] This selective estrogen receptor modulator (SERM)-like behavior makes its net estrogenic effect difficult to predict.
Implications for Men
For most healthy men taking resveratrol at 150–500 mg/day, the estrogenic activity is unlikely to produce noticeable clinical effects. Still, this property warrants caution in specific populations:
- Men on testosterone replacement therapy (TRT): testosterone can be aromatized to estradiol, and adding a phytoestrogen may compound estrogenic activity. Monitoring estradiol levels through regular bloodwork is advisable, ideally under physician-supervised TRT in Miami
- Men with gynecomastia concerns: individuals already managing elevated estrogen or estrogen-related symptoms should discuss resveratrol with their physician
- Men with estrogen-sensitive conditions: though rare, some male cancers (certain breast cancers) are estrogen-receptor positive
The bottom line: resveratrol's estrogenic activity is real but context-dependent. At typical supplemental doses, it's unlikely to meaningfully shift estrogen levels in healthy men, but it's a factor worth considering, particularly for men already managing hormone balance.
Which medications interact with resveratrol?
Resveratrol interacts with medications by inhibiting several cytochrome P450 enzymes. In 42 healthy volunteers, 1 g a day for four weeks inhibited CYP3A4, CYP2D6 and CYP2C9 and induced CYP1A2, the liver enzymes that break down a huge proportion of common drugs.[7][8]
- CYP3A4: metabolizes approximately 50% of all drugs, including statins (atorvastatin, simvastatin), calcium channel blockers, immunosuppressants (cyclosporine, tacrolimus), and some anti-anxiety medications
- CYP2D6: metabolizes many antidepressants (SSRIs, SNRIs), beta-blockers, and opioid pain medications
- CYP1A2: metabolizes caffeine, certain antipsychotics, and theophylline
When these enzymes are inhibited, the drugs they normally process can accumulate to higher-than-intended blood levels, potentially increasing both therapeutic effects and side effects. For men taking statins, for example, CYP3A4 inhibition by resveratrol could increase the risk of statin-related myopathy (muscle damage).
Medications That Require Caution
- Statins (atorvastatin, simvastatin; less concern with rosuvastatin, which uses different pathways)
- Blood pressure medications (especially calcium channel blockers)
- Blood thinners (warfarin, DOACs)
- Antidepressants (SSRIs, SNRIs)
- Immunosuppressants
- Erectile dysfunction medications (sildenafil, tadalafil; metabolized by CYP3A4)
- Benzodiazepines (alprazolam, midazolam)
Men taking prescription medications, especially multiple medications, should consult their pharmacist or physician before adding resveratrol to their regimen. A drug interaction check takes minutes and could prevent serious complications.
Does resveratrol affect the kidneys?
High-dose resveratrol (2,500 mg a day and above) has been associated in some reports with changes in kidney function markers, and the published phase I data do not establish renal safety at those doses.[2] That raises caution for men with pre-existing kidney disease or those taking nephrotoxic medications.
Men with known kidney issues or those taking medications that affect kidney function should have their renal markers monitored if using resveratrol, even at moderate doses.
Who should avoid resveratrol?
Based on the evidence reviewed, the following groups should either avoid resveratrol or use it only under medical supervision:
- Men taking anticoagulant or antiplatelet medications
- Men scheduled for surgery within 2 weeks
- Men taking CYP3A4-metabolized medications (statins, immunosuppressants, PDE5 inhibitors)
- Men with active bleeding disorders
- Men with estrogen-sensitive conditions
- Men with kidney disease
How do you decide whether to take resveratrol?
At reasonable doses, resveratrol isn’t dangerous for healthy men. But it’s also not the harmless wellness supplement that marketing copy would have you believe. Once you understand the GI effects, the blood-thinning properties, the estrogenic activity, and most importantly the drug interactions, you can make a genuinely informed decision about whether it belongs in your regimen.
Before starting any new supplement, especially one with documented drug interactions, getting a clear picture of your current health status is essential. Complete lab testing can establish baseline kidney function, liver enzymes, hormone levels, and coagulation markers. This data makes it possible to track the impact of any intervention and catch potential issues early.
A preventive health strategy grounded in data is always more effective than a supplement-first approach. Know your numbers, understand the risks, and make decisions accordingly.
Frequently Asked Questions
What are the most common resveratrol side effects?
Does resveratrol thin the blood?
Is resveratrol estrogenic? Should men be concerned?
Can resveratrol interact with medications?
How much resveratrol is safe to take?
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. Authorship and review information are shown where recorded; an editorial update is not a new medical review.
Looking for care? View Strong Health locations and visit options.
Ready to Talk to a Doctor?
Strong Health offers physician-supervised treatment plans tailored to your needs. No judgment. No pressure. Just answers.
References & Citations
- Boocock DJ, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1246-1252.
- Brown VA, et al. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res. 2010;70(22):9003-9011.
- Bertelli A, et al. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue React. 1995;17(1):1-3.
- Pace-Asciak CR, et al. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis. Clin Chim Acta. 1995;235(2):207-219.
- Gehm BD, et al. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA. 1997;94(25):14138-14143.
- Bowers JL, et al. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology. 2000;141(10):3657-3667.
- Chow HH, et al. Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev Res. 2010;3(9):1168-1175.
- Detampel P, et al. Drug interaction potential of resveratrol. Drug Metab Rev. 2012;44(3):253-265.